Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This document is a response-to-comments article for proposed policy A59578 regarding amniotic and placental-derived product injections/applications for musculoskeletal, non-wound indications; the provided excerpt contains no substantive coverage criteria, limitations, documentation requirements, or frequency limits. Extraction is incomplete — review the full final MAC policy A59578 to obtain actionable coverage criteria and supporting documentation requirements.

"No specific coverage indications for amniotic or placental-derived product injections/applications for musculoskeletal (non-wound) conditions are present in the provided document; consult the final..."

Sign up to see full coverage criteria, indications, and limitations.